Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Kuraya Sanseido Aims at Consolidated Sales of \1,330 Bil. in FY2004
March 11, 2002
- GE Maker Lost the Game: Mr Sawai
March 11, 2002
- Hokuriku: Sales Increase by 22% to \24.9 Bil.
March 11, 2002
- New SMO Industry Organization to Be Created in April
March 11, 2002
- Otsuka's POCARI Drink Inhibits Increases in Blood Viscosity
March 11, 2002
- SSRI 20th Anniversary Seminar
March 11, 2002
- Sunstar to Report Anti-allergic Effects of Persimmon Leaf Extract
March 11, 2002
- RAD-AR Proposes to Korosho to Use Reexamination Data to Construct Database
March 11, 2002
- Glaucoma Testing Not Conducted in 80% of Municipalities in Tokyo
March 11, 2002
- BUSINESS NEWS IN BRIEF
March 11, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 11, 2002
- 7 Drugs Approved, Including Sivelestat
March 11, 2002
- MEDICAL DEVICE NEWS IN BRIEF
March 11, 2002
- Committee to Propose Basic Policy for Science and Technology
March 11, 2002
- WORLD NEWS IN BRIEF
March 11, 2002
- IFN Prices to Be Cut by 25%
March 11, 2002
- BULLETIN
March 11, 2002
- WEBSIITE NEWS
March 11, 2002
- Maruishi: Sales, Profits Up due to Increases in Exports
March 11, 2002
- Gov't to Formulate Basic Policy for New Healthcare System for Elderly in FY2002
March 11, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…